Escherichia coli


Escherichia coli is an important cause of intraintestinal and extraintestinal infections. Intraintestinal infections present as different diarrheal illnesses. Extraintestinal infections include disease of the urinary tract (see Chapter 553 ) and bloodstream ( Chapter 129, Chapter 202, Chapter 203 ). Intraintestinal pathogenic E. coli , also called enteric E. coli , produce diarrheal diseases. E. coli causing extra- and intraintestinal infections are highly specialized with unique genetic attributes that encode different sets of virulence factors and genetic programs. Extraintestinal pathogenic E. coli increasingly harbor multidrug resistances, including transferrable plasmids resulting in extended-spectrum β-lactamase (ESBL) production. This results in resistance to penicillins, cephalosporins, and aztreonam. Carbapenemase-bearing E. coli have also emerged, often in combination with multi–antibiotic class resistance, resulting in highly drug-resistant strains.

Escherichia coli species are members of the Enterobacteriaceae family. They are facultative anaerobic, gram-negative bacilli that usually ferment lactose. Most fecal E. coli organisms are commensal, are ubiquitous among humans starting in the 1st mo of life, and do not cause diarrhea. Six major groups of diarrheagenic E. coli pathotypes have been characterized on the basis of clinical, biochemical, and molecular-genetic criteria: enterotoxigenic E. coli (ETEC); enteroinvasive E. coli (EIEC); enteropathogenic E. coli (EPEC); Shiga toxin–producing E. coli (STEC), also known as enterohemorrhagic E. coli (EHEC) or verotoxin-producing E. coli (VTEC); enteroaggregative E. coli (EAEC or EggEC); and diffusely adherent E. coli (DAEC).

E. coli strains can also be categorized by their serogroup, where O refers to the lipopolysaccharide (LPS) O-antigen or serotype and H refers to the flagellar antigen, for example , E. coli O157:H7. However, because each pathotype contains many serotypes (e.g., 117 ETEC serotypes have been identified), and some serotypes can belong to more than 1 pathotype (e.g., O26:H11 can be either EPEC or EHEC, depending on which specific virulence genes are present), serotyping frequently does not provide definitive identification of pathotypes.

Because E. coli are normal fecal flora, pathogenicity is defined by demonstration of virulence characteristics and association of those traits with illness ( Table 227.1 ). The mechanism by which E. coli produces diarrhea typically involves adherence of organisms to a glycoprotein or glycolipid receptor on a target intestinal cell, followed by production of a factor that injures or disturbs the function of intestinal cells. The genes for virulence properties and antibiotic resistance are often carried on transferable plasmids, pathogenicity islands, or bacteriophages. In the developing world, the various diarrheagenic E. coli strains cause frequent infections in the 1st years of life; diarrheagenic E. coli as a group are responsible for 30-40% of all diarrhea cases in children worldwide. They occur with increased frequency during the warm months in temperate climates and during rainy season months in tropical climates. Most diarrheagenic E. coli strains (except STEC) require a large inoculum of organisms to induce disease, thus necessitating exposure to grossly contaminated ingestible materials. Infection is most likely when food-handling or sewage-disposal practices are suboptimal. The diarrheagenic E. coli pathotypes are also important in North America and Europe, although their epidemiology is less well defined in these areas than in the developing world. In North America, the various diarrheagenic E. coli strains may cause as much as 30% of infectious diarrhea in children <5 yr old.

Table 227.1
Clinical Characteristics, Pathogenesis, and Diagnosis of Diarrheagenic E. coli
PATHOGEN POPULATIONS AT RISK CHARACTERISTICS OF DIARRHEA MAIN VIRULENCE FACTORS DIAGNOSIS
Watery Bloody Duration Adherence Factors Toxins
ETEC >1 yr old and travelers +++ Acute Colonization factor antigens (CFs or CFAs); ECP Heat-labile enterotoxin (LT)
Heat-stable enterotoxin (ST)
Detection of enterotoxins (LT and ST) by enzyme immunoassays or PCR ( lt, st )
EIEC >1 yr old + ++ Acute Invasion plasmid antigen (IpaABCD) Detection of invasion plasmid antigen of Shigella ( ipaH ) by PCR
EPEC <2 yr old +++ + Acute, prolonged or persistent A/E lesion, intimin/Tir, EspABD, Bfp EspF, Map, EAST1, SPATEs ( EspC ) Detection of intimin gene ( eae ) ± bundle-forming pili ( bfp A) by PCR, and absence of Shiga toxins; HEp-2 cells adherence assay (LA, LLA)
STEC (EHEC/VTEC) 6 mo-10 yr and elderly persons + +++ Acute A/E lesion, intimin/Tir, EspABD Shiga toxins (Stx1, Stx2, and variants of Stx2) Detection of Shiga toxins by enzyme immunoassays or PCR ( Stx 1, Stx 2); stool culture on MacConkey-sorbitol media to detect E. coli O157. Simultaneous culture for O157 and nonculture assays to detect Shiga toxins
EAEC <2 yr old, HIV-infected patients, and travelers +++ + Acute, prolonged, or persistent Aggregative adherence fimbriae (AAF) SPATEs (Pic, Pet), ShET1, EAST1 Detection of AggR , AA plasmid, and other virulence genes: aap , aa t A , astA , set1A by PCR; HEp-2 cells adherence assay (AA)
DAEC >1 yr old and travelers ++ Acute Afa/Dr, AIDA-I SPATEs (Sat) Detection of Dr adhesins (daaC or daaD) and Dr-associated genes by PCR; HEp-2 cells adherence assay (DA)
—, Not present; +, present; ++, common; +++, very common; A/E lesion, attaching and effacing lesion; AA, aggregative adherence; Bfp, bundle-forming pili; DA, diffuse adherence; DAEC, diffusely adherent E. coli; EAEC, enteroaggregative E. coli; EAST1, enteroaggregative heat-stable toxin; ECP, E. coli common pilus; EHEC, enterohemorrhagic E. coli; EIEC, enteroinvasive E. coli; EPEC, enteropathogenic E. coli ; EspABD, E. coli –secreted proteins A, B, and D; ETEC, enterotoxigenic E. coli; LA, localized adherence; LLA, localized-like adherence; PCR, polymerase chain reaction; ShET1, Shigella enterotoxin 1; SPATEs, serine-protease autotransporter of Enterobacteriaceae; STEC, Shiga toxin–producing E. coli ; Tir, translocated intimin receptor; VTEC, verotoxin-producing E. coli.

Many studies have found diarrheagenic E. coli pathotypes in a significant proportion of asymptomatic healthy children living in developing countries. Fecal contamination (human and animal), which is common in the low-resource environments where many young children live, facilitates the transmission of pathogens. Also, with modern, highly sensitive microbiologic methods, small numbers of bacteria can be detected in stool samples. Therefore, it is important to assess the prevalence of various enteropathogens in children with and without diarrhea to interpret results. Excretion of enteropathogens by children without diarrhea may be explained by characteristics of the pathogens (virulence heterogeneity), the host (host susceptibility, age, nutritional status, breastfeeding, immunity), and environmental factors (inoculum size).

Enterotoxigenic Escherichia coli

ETEC accounts for a sizable fraction of dehydrating infantile diarrhea in the developing world (10–30%) and of traveler's diarrhea (20–60% of cases); ETEC is the most common cause of traveler's diarrhea. In the Global Enteric Multicenter Study (GEMS) conducted across Asia and Africa, heat-stable enterotoxin (ST)–expressing ETEC (with or without coexpression of heat-labile enterotoxin [LT]) was among the most important causes of diarrhea in young children in developing countries and was associated with increased risk of death. The typical signs and symptoms include explosive watery, nonmucoid, nonbloody diarrhea; abdominal pain; nausea; vomiting; and little or no fever. The illness is usually self-limited and resolves in 3-5 days but occasionally lasts >1 wk.

ETEC causes few or no structural alterations in the gut mucosa. Diarrhea follows colonization of the small intestine and elaboration of enterotoxins. ETEC strains secrete an LT and/or an ST. LT, a large molecule consisting of 5 receptor-binding subunits and 1 enzymatically active subunit, is structurally, functionally, and neutralizing antibody cross-reactive with cholera toxin produced by Vibrio cholerae . LT stimulates adenylate cyclase, resulting in increased cyclic adenosine monophosphate. ST is a small molecule not related to cholera toxin. ST stimulates guanylate cyclase, resulting in increased cyclic guanosine monophosphate. Each toxin induces ion and water secretion into the intestinal lumen, resulting in profuse watery diarrhea. The genes for these toxins are encoded on plasmids.

Colonization of the intestine requires fimbrial colonization factor antigens (CFAs) , which promote adhesion to the intestinal epithelium. Over 25 CFA types exist and can be expressed alone or in combinations. Prevalent colonization factors include CFA/I, CS1-CS7, CS14, and CS17. However, CFAs have not been detected on all ETEC strains. Although 30–50% of ETEC isolates have no characterized CFA by phenotypic screening, novel CFAs continue to be identified. CFAs are highly immunogenic. However, the multiple CFAs and their allelic variants have made the definition of immunity and development of useful vaccines difficult. A large proportion of strains produce a type IV pilus called longus , which functions as a colonization factor and is found among several other gram-negative bacterial pathogens. ETEC strains also have the common pilus, produced by commensal and pathogenic E. coli strains. Among the nonfimbrial adhesions, TibA is a potent bacterial adhesin that mediates bacterial attachment and invasion of cells. For many years, the O serogroup was used to distinguish pathogenic from commensal E. coli . Because the pathogenic E. coli are now defined and classified by using probes or primers for specific virulence genes, determining the O serogroup has become less important. Of the >180 E. coli serogroups, only a relatively small number typically are ETEC. The most common O groups are O6, O8, O128, and O153, and based on some large retrospective studies, these serogroups account for only half the ETEC strains.

Enteroinvasive Escherichia coli

Clinically, EIEC infections present either with watery diarrhea or a dysentery syndrome with blood, mucus, and leukocytes in the stools, as well as fever, systemic toxicity, crampy abdominal pain, tenesmus, and urgency. The illness resembles bacillary dysentery because EIEC shares virulence genes with Shigella spp. Sequencing of multiple housekeeping genes indicates that EIEC is more related to Shigella than to noninvasive E. coli . EIEC diarrhea occurs mostly in outbreaks; however, endemic disease occurs in developing countries. In some areas of the developing world as many as 5% of sporadic diarrhea episodes and 20% of bloody diarrhea cases are caused by EIEC (see Chapter 226 ).

EIEC disease resembles shigellosis . EIEC cause colonic lesions with ulcerations, hemorrhage, mucosal and submucosal edema, and infiltration by polymorphonuclear leukocytes (PMNs). EIEC strains behave like Shigella in their capacity to invade gut epithelium and produce a dysentery-like illness. The invasive process involves initial entry into cells, intracellular multiplication, intracellular and intercellular spread, and host cell death. All bacterial genes necessary for entry into the host cell are clustered within a 30-kb region of a large virulence plasmid; these genes are closely related to those found on the invasion plasmid of Shigella spp. This region carries genes encoding the entry-mediating proteins, including proteins that form a needle-like injection apparatus called type III secretion, required for secreting the invasins (IpaA-D and IpgD). The Ipas are the primary effector proteins of epithelial cell invasion. The type III secretion apparatus is a system triggered by contact with host cells; bacteria use it to transport proteins into the host cell plasma membrane and inject toxins into the host cell cytoplasm.

EIEC encompasses a small number of serogroups (O28ac, O29, O112ac, O124, O136, O143, O144, O152, O159, O164, O167, and some untypeable strains). These serogroups have LPS antigens related to Shigella LPS, and as with shigellae, are nonmotile (they lack H or flagellar antigens) and are usually non–lactose fermenting.

Enteropathogenic Escherichia coli

EPEC causes acute, prolonged, and persistent diarrhea, primarily in children <2 yr old in developing countries, where the organism may account for 20% of infant diarrhea. In developed countries, EPEC cause occasional daycare center and pediatric ward outbreaks. Profuse watery, nonbloody diarrhea with mucus, vomiting, and low-grade fever are common symptoms. Prolonged diarrhea (>7 days) and persistent diarrhea (>14 days) can lead to malnutrition , a potentially mortality-associated outcome of EPEC infection in infants in the developing world. Studies show that breastfeeding is protective against diarrhea caused by EPEC.

EPEC colonization causes blunting of intestinal villi, local inflammatory changes, and sloughing of superficial mucosal cells; EPEC-induced lesions extend from the duodenum through the colon. EPEC induces a characteristic attaching and effacing histopathologic lesion, which is defined by the intimate attachment of bacteria to the epithelial surface and effacement of host cell microvilli. Factors responsible for the attaching and effacing lesion formation are encoded by the locus of enterocyte effacement (LEE), a pathogenicity island with genes for a type III secretion system, the translocated intimin receptor (Tir) and intimin, and multiple effector proteins such as the E. coli –secreted proteins (EspA-B-D). Some strains adhere to the host intestinal epithelium in a pattern known as localized adherence , a trait that is mediated in part by the type IV bundle-forming pilus (Bfp) encoded by a plasmid (the EAF plasmid). After initial contact, proteins are translocated through filamentous appendages forming a physical bridge between the bacteria and the host cell; bacterial effectors (EspB, EspD, Tir) are translocated through these conduits. Tir moves to the surface of host cells, where it is bound by a bacterial outer membrane protein intimin (encoded by the eae gene). Intimin-Tir binding triggers polymerization of actin and other cytoskeletal components at the site of attachment. These cytoskeletal changes result in intimate bacterial attachment to the host cell, enterocyte effacement, and pedestal formation.

Other LEE-encoded effectors include Map, EspF, EspG, EspH, and SepZ. Various other effector proteins are encoded outside the LEE and secreted by the type III secretion system (the non–LEE-encoded proteins, or Nle). The contribution of these putative effectors (NleA/EspI, NleB, NleC, NleD, etc.) to virulence is still under investigation. The presence and expression of virulence genes vary among EPEC strains.

The eae (intimin) and bfp A genes are useful for identifying EPEC and for subdividing this group of bacteria into typical and atypical strains. E. coli strains that are eae + / bfp A + are classified as “typical” EPEC; most of these strains belong to common O:H serotypes. E. coli strains that are eae + / bfp A are classified as “atypical” EPEC. Typical EPEC has been considered for many years to be a leading cause of infantile diarrhea in developing countries and was considered rare in industrialized countries. However, current data suggest that atypical EPEC are more prevalent than typical EPEC in both developed and developing countries, even in persistent diarrhea cases. Determining which of these heterogeneous strains are true pathogens remains a work in progress. In the GEMS, typical EPEC was the main pathogen associated with increased risk of mortality, particularly in infants in Africa.

The classic EPEC serogroups include strains of 12 O serogroups: O26, O55, O86, O111, O114, O119, O125, O126, O127, O128, O142, and O158. However, various E. coli strains defined as EPEC based on the presence of the intimin gene belong to nonclassic EPEC serogroups, especially the atypical strains.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here